Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes
Marie-Sophie Meuleman(Université Paris Cité), Camille Cohen(Inserm), Juliette Gueguen(Inserm), Gillian Divard(Inserm), Olivier Aubert(Hôpital Necker-Enfants Malades), Steven Mouyabi(Centre Hospitalier Universitaire de Poitiers), Stéphanie Vicca(Hôpital Necker-Enfants Malades), Frank Bienaimé(Hôpital Necker-Enfants Malades), Frank Bridoux(Université de Poitiers), Dany Anglicheau(Délégation Paris 5), Bertrand Arnulf(Université Paris Cité)
Cited by 3
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695